Localization of a nonintercalative DNA binding antitumour drug in mitochondria: Relationship to multidrug resistance
- 1 September 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (9) , 1287-1293
- https://doi.org/10.1016/0277-5379(89)90075-8
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Relationship between the structure of analogues of amsacrine and their degree of cross-resistance to adriamycin-resistant P388 leukaemia cellsEuropean Journal of Cancer and Clinical Oncology, 1988
- Nonintercalating DNA-binding ligands: Specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic materialProgress in Biophysics and Molecular Biology, 1986
- The use of human cancer cell lines as a primary screening system for antineoplastic compoundsEuropean Journal of Cancer and Clinical Oncology, 1984
- Anticarcinoma Activity in Vivo of Rhodamine 123, a Mitochondrial-Specific DyeScience, 1983
- Nonintercalative DNA-binding antitumour compoundsMolecular and Cellular Biochemistry, 1982
- Existence of an extended series of antitumor compounds which bind to deoxyribonucleic acid by nonintercalative meansBiochemistry, 1980
- A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2JNCI Journal of the National Cancer Institute, 1973
- Potential antitumor agents. X. Bisquaternary saltsJournal of Medicinal Chemistry, 1969
- Potential Antitumor Agents. V. Bisquaternary SaltsJournal of Medicinal Chemistry, 1967
- Biophysikalische Studien mit synthetischem Lecithin als Weg zu neuartigen ChemotherapeutikaCellular and Molecular Life Sciences, 1961